BrainsWay Q2 FY26 adjusted EBITDA more than doubles to USD 3.5 million; revenue rises 35% to USD 17.1 million
BWAY•Full-year outlook raised
Raised FY 2026 outlook: revenue $68 million-$70 million; adjusted EBITDA $13 million-$14 million, citing stronger reimbursement coverage and utilization.
System shipments and backlog grow
Deep TMS system shipments increased 42% to 125; installed base reached about 1,949, while RPOs grew 30% to $80.4 million.
Q2 revenue and profit rise sharply
BrainsWay Q2 2026 revenue rose 35% to $17.1 million; IFRS net income climbed 34% to $2.7 million.
IFRS operating income jumped more than 300% to $2.4 million; operating margin widened 9 percentage points to 14%.
Non-IFRS adjusted EBITDA more than doubled to $3.5 million; adjusted EBITDA margin expanded 9 percentage points to 20%.
